GSC
OMED

Ground Swell Capital’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Ground Swell Capital’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1K Sell
51
-62
-55% -$1.25K ﹤0.01% 2358
2014
Q2 		$3K Buy
+113
New +$2.79K 0.01% 1437

Other funds holding OMED

SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ground Swell Capital's OMED Position: Q3 2014 in Review

Ground Swell Capital reduced its OncoMed Pharmaceuticals, Inc. (OMED) stake by 55% in Q3 2014, selling an estimated $1.25K and leaving 51 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2358.

Ground Swell Capital first reported a position in OMED in Q2 2014 and has held it in 2 quarters since. The position peaked at $3K in Q2 2014. 62 funds tracked by Wall St. Rank hold OMED as of Q3 2014.

  • Ground Swell Capital held 51 shares of OncoMed Pharmaceuticals, Inc. worth $1K as of Q3 2014.
  • Ground Swell Capital sold 62 OncoMed Pharmaceuticals, Inc. shares in Q3 2014, an estimated $1.25K.
  • OncoMed Pharmaceuticals, Inc. made up ﹤0.01% of Ground Swell Capital's portfolio in Q3 2014, its #2358 holding.
  • Ground Swell Capital first reported a position in OncoMed Pharmaceuticals, Inc. in Q2 2014 and has held it in 2 quarters since.
  • Ground Swell Capital's OncoMed Pharmaceuticals, Inc. position peaked at $3K in Q2 2014.
  • 62 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.